The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
18 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $11,674,408 in first-year total cost, median $668,972.
Most frequent study sections
- Special Emphasis Panel[ZRG1 MCST-M (81)]14
- Advancing Therapeutics - B Study Section[ATB]3
- Special Emphasis Panel[ZRG1-MCST-M(81)S]1
Most frequent institutions
- UNIVERSITY OF COLORADO DENVER2
- ARKANSAS CHILDREN'S HOSPITAL RES INST1
- BAYLOR COLLEGE OF MEDICINE1
- DUKE UNIVERSITY1
- HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | In-depth characterization of myeloid cells in human milk from HIV- and HIV+ donors as potential vehicles of and defenders against vertical transmission of HIV: essential data for targeted therapeutics1R01AI182586-01A1 | POWELL, REBECCA | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $850,491 | ZRG1 |
| 2025 | Using a Large Electronic Health Record Database to Characterize SSRI's Effect on Height Growth1R56HD116951-01 | CALARGE, CHADI A.CHEN, HUA | UNIVERSITY OF HOUSTON, TX | $846,528 | ZRG1 |
| 2025 | Evaluating Maternal and Neonatal Pharmacokinetics of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators - The ELECTRA Pregnancy Study1R01HD117940-01 | GUIMBELLOT, JENNIFER SSINKEY, RACHEL G | ARKANSAS CHILDREN'S HOSPITAL RES INST, AR | $696,246 | ATB |
| 2025 | Mechanistic Pathways of Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females at Risk of Iron Deficiency Anemia1R01HD114624-01A1 | KOENIG, MARY DAWN | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $689,134 | ATB |
| 2025 | Dose based aspirin pharmacokinetics and pharmacodynamics in pregnancy and association with pregnancy outcomes1R01HD112076-01A1 | BOELIG, RUPSA CHAUDHURY | THOMAS JEFFERSON UNIVERSITY, PA | $678,809 | ZRG1 |
| 2025 | Impact of obesity treatments on subsequent pregnancy outcomes2R01HD097778-06A1 | HERNANDEZ-DIAZ, SONIA | HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, MA | $659,135 | ATB |
| 2025 | Placental Proteins and Prematurity1R01HD116753-01 | JANSSON, THOMAS | UNIVERSITY OF COLORADO DENVER, CO | $641,883 | ZRG1 |
| 2025 | Optimizing Neuroprotective Strategies for HIE in Low- and Middle-Resource Settings (LMIC neuroprotection)1R01HD114573-01A1 | NANCE, ELIZABETH AWOOD, THOMAS | UNIVERSITY OF WASHINGTON, WA | $615,478 | ZRG1 |
| 2025 | An Engineered Human Ductus Arteriosus Capable of Biomimetic Response to Vasoactive Agents1R01HD116762-01 | BELLAN, LEON MARCELSHELTON, ELAINE L. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $590,565 | ZRG1 |
| 2025 | Optimizing Caffeine Therapy for Hypoxia in Preterm Neonates: A Randomized Trial Assessing Efficacy, Acute Kidney and Brain Injury, Safety, and Pharmacokinetics1R01HD116793-01 | HARER, MATTHEW | UNIVERSITY OF WISCONSIN-MADISON, WI | $421,691 | ZRG1 |
| 2024 | Neonatal, Lactation, and Child Health Outcomes Following RSV Vaccination During Pregnancy1R01HD115580-01 | PALMSTEN, KRISTIN | HEALTHPARTNERS INSTITUTE, MN | $732,591 | ZRG1 |
| 2024 | Long-term Trajectory of SSRI-Induced Height Growth Suppression1R01HD115645-01 | CALARGE, CHADI A. | BAYLOR COLLEGE OF MEDICINE, TX | $707,858 | ZRG1 |
| 2024 | MiMA: Mother-infant Metabolite-transporter Atlas1R01HD114758-01 | CHANG, GEOFFREY AGHOSH, PRADIPTASTOWELL, MICHAEL H. B.SUHANDYNATA, RAYMOND THEODORE | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $697,803 | ZRG1 |
| 2024 | A novel live biologic for the prevention and treatment of NEC-induced neurodevelopmental impairment1R01HD116839-01 | BAILEY, MICHAEL TBESNER, GAIL EGOODMAN, STEVEN D | RESEARCH INST NATIONWIDE CHILDREN'S HOSP, OH | $683,916 | ZRG1 |
| 2024 | IL-10 Delivery Using Extracellular Vesicles to Delay Preterm Birth1R01HD114744-01 | ADAMS WALDORF, KRISTINA M.KAMMALA, ANANTH KUMARMENON, RAMKUMAR | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $635,254 | ZRG1 |
| 2024 | Understanding the underlying toxicological mechanisms of drug-hormone interactions to improve the safety profile of antiviral medications in pregnant people, developing fetuses, and neonates1R01AI183687-01 | LAMPE, JED NOAH | UNIVERSITY OF COLORADO DENVER, CO | $631,055 | ZRG1 |
| 2024 | Oxytocin for induction of labor: understanding goals and mechanisms1R01HD115637-01 | FROLOVA, ANTONINA IRAGHURAMAN, NANDINI | WASHINGTON UNIVERSITY, MO | $497,504 | ZRG1 |
| 2024 | Revolutionizing Pediatric Tonsillectomy Pharmacology and Therapeutics1R01HD114678-01 | EINHORN, LISA M. | DUKE UNIVERSITY, NC | $398,467 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.